Fig. 1From: Hepatic hypertrophy and hemodynamics of portal venous flow after percutaneous transhepatic portal embolizationIR-RLV according to the presence of favorable conditions, namely an IR-pFV on day 3 ≥ 100% and an ICGR15 ≤ 15%. Patients with an IR-pFV on 3 days after PTPE ≥100% and an ICGR15 ≤ 15% (favorable group) exhibited a significantly increased IR-RLV compared with other patients (unfavorable group) (P < 0.01)Back to article page